PHENDIMETRAZINE TARTRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phendimetrazine Tartrate, and when can generic versions of Phendimetrazine Tartrate launch?
Phendimetrazine Tartrate is a drug marketed by Acertis Pharms, Graham Dm, Virtus, Sandoz, Vitarine, Barr, Chartwell, Chartwell Rx, Elite Labs Inc, Ferndale Labs, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Mpp Pharma, Nexgen Pharma Inc, Numark, Pvt Form, Solvay, Upsher Smith Labs, Usl Pharma, and Watson Labs. and is included in sixty-five NDAs.
The generic ingredient in PHENDIMETRAZINE TARTRATE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phendimetrazine Tartrate
A generic version of PHENDIMETRAZINE TARTRATE was approved as phendimetrazine tartrate by CHARTWELL on October 30th, 1991.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PHENDIMETRAZINE TARTRATE?
- What are the global sales for PHENDIMETRAZINE TARTRATE?
- What is Average Wholesale Price for PHENDIMETRAZINE TARTRATE?
Summary for PHENDIMETRAZINE TARTRATE
| US Patents: | 0 |
| Applicants: | 24 |
| NDAs: | 65 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 547 |
| Drug Prices: | Drug price information for PHENDIMETRAZINE TARTRATE |
| What excipients (inactive ingredients) are in PHENDIMETRAZINE TARTRATE? | PHENDIMETRAZINE TARTRATE excipients list |
| DailyMed Link: | PHENDIMETRAZINE TARTRATE at DailyMed |
Pharmacology for PHENDIMETRAZINE TARTRATE
| Drug Class | Sympathomimetic Amine Anorectic |
| Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
US Patents and Regulatory Information for PHENDIMETRAZINE TARTRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kv Pharm | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 084141-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ferndale Labs | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 086834-001 | Sep 15, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pvt Form | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 085697-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Vitarine | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 086005-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mpp Pharma | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 203600-001 | Dec 27, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 085402-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
